Estrogen therapy: is time of initiation critical for neuroprotection? (Q37618547)

21 August 2017

1 reference

title

Estrogen therapy: is time of initiation critical for neuroprotection? (English)

1 reference

21 August 2017

1 reference

1

Barbara B Sherwin

1 reference

21 August 2017

1 November 2009

1 reference

Nature Reviews Endocrinology

21 August 2017

1 reference

21 August 2017

5

1 reference

21 August 2017

11

1 reference

21 August 2017

620-627

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2009.193

21 August 2017

0 references

cites work

Selective decline in memory function among healthy elderly.

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Cognitive performance in surgically menopausal women on estrogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Cognitive function in nondemented older women who took estrogen after menopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Estrogen replacement therapy and cognitive decline in older community women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Neurotrophin expression in the reproductively senescent forebrain is refractory to estrogen stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Individual differences in rates of change in cognitive abilities of older persons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Changes in memory processing with age.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Effect of age on forward and backward digit spans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Life and death of neurons in the aging brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Estrogen actions throughout the brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

31 March 2020

12 December 2020

Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons.

2 references

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

31 March 2020

12 December 2020

Memory retention is modulated by acute estradiol and progesterone replacement

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Effects of estrogen on memory function in surgically menopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Better oral reading and short-term memory in midlife, postmenopausal women taking estrogen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Estrogen and cognition: applying preclinical findings to clinical perspectives

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Hormone therapy and risk of Alzheimer disease: a critical time.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Effects of gonadal hormone replacement on measures of basal forebrain cholinergic function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Early postmenopausal hormone therapy may prevent cognitive impairment later in life

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Estrogen therapy and risk of cognitive decline: results from the Women's Estrogen for Stroke Trial (WEST).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Short-term transdermal estradiol therapy, cognition and depressive symptoms in healthy older women. A randomised placebo controlled pilot cross-over study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

The effect of 3-year treatment with 0.25 mg/day of micronized 17beta-estradiol on cognitive function in older postmenopausal women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Sex steroids modify working memory

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Effects of hormone replacement therapy on cognitive performance in elderly women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Two weeks of transdermal estradiol treatment in postmenopausal elderly women and its effect on memory and mood: verbal memory changes are associated with the treatment induced estradiol levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Longitudinal Magnetic Resonance Imaging Studies of Older Adults: A Shrinking Brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Clinical pharmacology and differential cognitive efficacy of estrogen preparations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Characteristics of the Modified Mini-Mental State Exam among elderly persons.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Hormone replacement therapy and cognition: systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Estradiol interacts with the cholinergic system to affect verbal memory in postmenopausal women: evidence for the critical period hypothesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women: The Kame Project

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Long-term estrogen replacement is associated with improved nonverbal memory and attentional measures in postmenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Effects of combination estrogen plus progestin hormone treatment on cognition and affect

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.193

Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society

31 March 2020

1 reference

PubMed

12 December 2020

Individual differences in cross-sectional and 3-year longitudinal memory performance across the adult life span.

1 reference

PubMed

12 December 2020

Estrogen and cerebral blood flow: a mechanism to explain the impact of estrogen on the incidence and treatment of Alzheimer's disease

1 reference

PubMed

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2009.193

1 reference

21 August 2017

1 reference

PubMed ID

19844249